Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...

Discover the latest advancements in BPDCN treatment, including targeted therapies and promising chemotherapy regimens for ...

On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...

Each type of cancer is unique, and there’s no one-size-fits-all treatment. Immunotherapy and targeted medications allow doctors to treat cancer using different approaches that help improve overall ...

For one Atlanta woman living with a chronic neurological condition, the post-holiday reset meant learning how to move again ...

Please provide your email address to receive an email when new articles are posted on . Adding on endotype-informed targeted combination therapies to oral appliance therapy helped reduce obstructive ...